DMRA
Damora Therapeutics, Inc.
20.70$
+2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Damora Therapeutics, Inc. (DMRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.5 | -11 | -5.9 | -4.1 | -3.7 | -4.9 | -2.4 | -2.2 | -2.6 | 0.6 | -21 | -22 | -45 | |
| 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | |
| – | – | – | – | 0.7 | 0.3 | 0.2 | 0.2 | 0.2 | 0.5 | 3.1 | 6.1 | 9.9 | |
| -2.0 | -6.2 | -1.9 | 0.2 | -0.6 | -0.3 | -0.1 | 1.0 | 0.3 | 17 | 4.0 | 3.2 | 25 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 8.3 | 9.6 | 5.7 | 6.0 | – | – | – | – | – | -17 | – | – | – | |
| 0.2 | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | 267 | 296 | 30 | – | |
| 0.1 | -1.6 | -0.4 | 1.8 | -3.7 | -4.9 | -2.4 | -2.2 | -2.6 | 250 | 275 | 7.6 | 530 | |
| -8.5 | -11 | -5.9 | -4.1 | -3.7 | -4.9 | -2.4 | -2.2 | -2.6 | 0.6 | -21 | -22 | -45 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.